KR101369252B1 - Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same - Google Patents
Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same Download PDFInfo
- Publication number
- KR101369252B1 KR101369252B1 KR1020120014223A KR20120014223A KR101369252B1 KR 101369252 B1 KR101369252 B1 KR 101369252B1 KR 1020120014223 A KR1020120014223 A KR 1020120014223A KR 20120014223 A KR20120014223 A KR 20120014223A KR 101369252 B1 KR101369252 B1 KR 101369252B1
- Authority
- KR
- South Korea
- Prior art keywords
- tofu
- coagulant
- black garlic
- concentrate
- calcium
- Prior art date
Links
- 235000013527 bean curd Nutrition 0.000 title claims abstract description 110
- 239000000701 coagulant Substances 0.000 title claims abstract description 69
- 241000383638 Allium nigrum Species 0.000 title claims abstract description 34
- 239000006000 Garlic extract Substances 0.000 title claims abstract description 21
- 235000020706 garlic extract Nutrition 0.000 title claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title description 16
- 229910001868 water Inorganic materials 0.000 title description 16
- 150000003839 salts Chemical class 0.000 title description 7
- 239000012267 brine Substances 0.000 claims abstract description 55
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims abstract description 55
- 239000012141 concentrate Substances 0.000 claims abstract description 38
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000011575 calcium Substances 0.000 claims abstract description 29
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 29
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000011777 magnesium Substances 0.000 claims abstract description 16
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 11
- 239000011734 sodium Substances 0.000 claims abstract description 11
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 11
- 235000013322 soy milk Nutrition 0.000 claims description 29
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 229910052710 silicon Inorganic materials 0.000 claims description 9
- 239000010703 silicon Substances 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- 238000000748 compression moulding Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 28
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 22
- 239000011707 mineral Substances 0.000 abstract description 22
- 235000019629 palatability Nutrition 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 7
- 235000010755 mineral Nutrition 0.000 description 21
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 10
- 230000015271 coagulation Effects 0.000 description 10
- 238000005345 coagulation Methods 0.000 description 10
- 240000002234 Allium sativum Species 0.000 description 9
- 235000010469 Glycine max Nutrition 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 235000004611 garlic Nutrition 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 238000001223 reverse osmosis Methods 0.000 description 6
- 239000013535 sea water Substances 0.000 description 6
- 229940001941 soy protein Drugs 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003673 groundwater Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- -1 magnesium chloride Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 229940032362 superoxide dismutase Drugs 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 239000000182 glucono-delta-lactone Substances 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000019600 saltiness Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/20—Ingredients acting on or related to the structure
- A23V2200/218—Coagulant
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
본 발명은 흑마늘 추출물 및 지하염수를 포함하는 두부용 응고제 및 이를 사용하여 제조된 두부에 관한 것으로, 보다 상세하게는 30 brix 농축액 기준으로 칼슘 50,000 내지 70,000 mg/l, 마그네슘 500 내지 1,000 mg/l 및 나트륨 15,000 내지 40,000 mg/l를 함유하는 지하염수의 농축액; 및 흑마늘 추출액;을 포함함으로써 인체에 무해하며, 천연 미네랄의 별도의 추가 공정 없이 기능성 및 기호성이 뛰어난 두부 및 그 제조방법에 관한 것이다.The present invention relates to a coagulant for tofu comprising black garlic extract and underground brine and tofu prepared using the same. More specifically, 50,000 to 70,000 mg / l calcium, 500 to 1,000 mg / l magnesium and 30 brix concentrate Concentrated brine containing 15,000 to 40,000 mg / l sodium; And black garlic extract; harmless to the human body by including, and relates to a tofu excellent in functionality and palatability without a separate additional process of natural minerals and a manufacturing method thereof.
Description
본 발명은 개선된 기능성 및 기호성을 갖는 두부용 응고제 및 이를 사용하여 제조된 두부에 관한 것이다.
The present invention relates to a coagulant for tofu having improved functionality and palatability and tofu prepared using the same.
두부는 우리나라의 전통식품으로 지금까지도 널리 애용되고 있는 식품 중의 하나이다. 이러한 두부의 제조는 콩으로부터 분리한 두유에 간수, 염화마그네슘, 황산칼슘 등과 같은 응고제를 혼합하여 숙성시킨 뒤, 이를 응고시켜 제조된다.Tofu is one of the traditional foods in Korea and is still widely used. This tofu is prepared by mixing coagulants such as liver water, magnesium chloride, calcium sulfate, and so on in soy milk separated from soybeans, and then coagulating them.
두부의 제조에 사용되는 응고제는 일반적으로 지효성 응고제와 속효성 응고제로 나뉘어진다.Coagulants used to prepare tofu are generally divided into slow-acting coagulants and fast-acting coagulants.
상기 지효성 응고제는 두유에 첨가시 약 5초~1분 내에 응고반응을 시작하는 두유 단백질과의 반응효과가 느린 응고제로, 황산칼슘, 글루코노델타락톤 등을 포함한다. 이러한 지효성 응고제는 그 반응속도가 느림으로 인해 보수성이 좋은 두부를 얻을 수 있기는 하나, 풍미가 좋은 두부를 얻을 수 없다는 단점이 있다.The slow-release coagulant is a coagulant having a slow reaction effect with a soymilk protein that starts a coagulation reaction within about 5 seconds to 1 minute when added to soymilk, and includes calcium sulfate, gluconodelta-laclactone, and the like. Such slow-acting coagulant can obtain tofu with good water retention due to the slow reaction rate, but has a disadvantage in that a flavor can not be obtained.
상기 속효성 응고제는 두유에 첨가시 약 1~2초 내에 응고반응을 시작하는 두유 단백질과의 반응효과가 빠른 응고제로, 염화마그네슘, 간수, 농축해수, 해수, 염화칼슘, 젖산 등과 같은 유기산 및 그 염 등이 포함된다. The fast-acting coagulant is a coagulant having a fast reaction effect with a soymilk protein that starts a coagulation reaction within about 1 to 2 seconds when added to soymilk. Organic acids such as magnesium chloride, liver water, concentrated seawater, seawater, calcium chloride, lactic acid and salts thereof This includes.
최근에는 저렴한 가격을 이유로 황산칼슘, 염화칼슘, 염화마그네슘, 글루코노델타락톤 등이 화학 응고제로 사용되고 있으며, 실제로 가장 많이 쓰이고 있는 응고제는 황산칼슘으로 대부분이 중국에서 수입되고 있다.Recently, calcium sulfate, calcium chloride, magnesium chloride, and glucono deltalactone are used as chemical coagulants due to the low price, and the most commonly used coagulant is calcium sulfate, which is mostly imported from China.
상기 황산칼슘을 응고제로 사용하는 두부의 제조는 그 수율이 매우 좋은 장점이 있으나 제조방법에 따라 회분이 초과되어 인체에 유해할 수 있는 문제점이 있었다. 또한, 상기 열거한 화학 응고제는 불수용성이 대부분이며, 일반적으로 침전현상이 일어나기 때문에 두부 전체에 고르게 퍼지지 않고 특정 부분에만 침전이 일어나 이를 섭취한 경우 인체에 유해할 수 있는 문제점이 있었다. 특히 종래에는 과량의 응고제를 제거하기 위하여 제조된 두부를 소정 시간동안 물에 담가 두어, 과량의 응고제를 제거하였다. 이 과정은 시간이 많이 필요하며 수율이 저하되는 문제가 있었다.The production of tofu using the calcium sulfate as a coagulant has the advantage that the yield is very good, but there is a problem that the ash content is exceeded depending on the manufacturing method, which may be harmful to the human body. In addition, the above-mentioned chemical coagulants are mostly insoluble in water, and in general, precipitation occurs, so that the precipitation does not spread evenly over the whole tofu but occurs only in specific portions, which may be harmful to the human body. In particular, conventionally, tofu prepared to remove excess coagulant was immersed in water for a predetermined time to remove excess coagulant. This process requires a lot of time and has a problem of lowering yield.
한국공개특허 제 2010-09111호(2010년 1월 27일 공개)에는 해양심층수로 제조된 천연 기능성 응고제 제조 기술과 그에 따른 천연 기능성 두부 제조 방법이 기재되어 있으나, 해양 심층수는 깊은 바다에서만 취수가 가능한 문제점이 있다.
Korean Patent Publication No. 2010-09111 (published Jan. 27, 2010) describes a technique for producing a natural functional coagulant prepared with deep seawater and a method for producing a natural functional tofu, but the deep sea water can be taken only from deep seas. There is a problem.
본 발명은 인공적인 합성 응고제가 아닌 자연에서 얻은 천연물로 제조되어 인체에 무해할 뿐만 아니라 미네랄 함량이 풍부한 두부용 응고제 및 이를 사용하여 제조된 두부를 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a coagulant for tofu and a tofu prepared using the same, which are made of natural products obtained from nature, not artificial artificial coagulants, which are harmless to the human body, and are rich in mineral content.
또한, 본 발명은 흑마늘의 우수한 건강기능성을 함유한 두부용 응고제 및 이를 사용하여 제조된 두부를 제공하는 것을 목적으로 한다.
It is also an object of the present invention to provide a coagulant for tofu containing the excellent health function of black garlic and tofu prepared using the same.
1. 30 brix 농축액 기준으로 칼슘 50,000 내지 70,000 mg/l, 마그네슘 500 내지 1,000 mg/l 및 나트륨 15,000 내지 40,000 mg/l를 함유하는 지하염수의 농축액; 및 흑마늘 추출액;을 포함하는 두부용 응고제.1. Concentrate of underground brine containing 50,000 to 70,000 mg / l calcium, 500 to 1,000 mg / l magnesium and 15,000 to 40,000 mg / l sodium on a 30 brix concentrate; And black garlic extract; Tofu coagulant comprising a.
2. 위 1에 있어서, 농축되기 전의 지하염수는 칼슘 4,000 내지 6,000 ppm, 마그네슘 20 내지 70 ppm 및 나트륨 1,500 내지 3,000 ppm을 함유하는 두부용 응고제.2. The coagulant for tofu according to the above 1, wherein the underground brine before concentration contains 4,000 to 6,000 ppm calcium, 20 to 70 ppm magnesium, and 1,500 to 3,000 ppm sodium.
3. 위 1에 있어서, 지하염수의 농축액은 30 brix 농축액 기준으로 규소 5 내지 20 mg/l 및 아연 5 내지 20 mg/l를 더 함유하는 두부용 응고제.3. according to the above 1, the brine concentrate is based on 30 brix concentrate based on more than 5 to 20 mg / l silicon and 5 to 20 mg / l coagulant for tofu.
4. 위 1에 있어서, 지하염수의 농축액과 흑마늘 추출액의 혼합 중량비는 70:30 내지 90:10인 두부용 응고제.4. In the above 1, the mixed weight ratio of the brine concentrate and black garlic extract is 70:30 to 90:10 coagulant for tofu.
5. 위 1 내지 4의 두부용 응고제로 제조된 두부.5. Tofu prepared by the coagulant for tofu of the above 1 to 4.
6. 위 5에 있어서, 칼슘 400 내지 550 mg/kg을 포함하는 두부.6. Tofu according to the above 5, containing 400 to 550 mg / kg calcium.
7. (S1) 지하염수를 위 1에 따른 농도를 가질 때까지 농축하는 단계; (S2) 상기 농축된 지하염수에 흑마늘 추출액을 혼합하여 두부용 응고제를 얻는 단계; (S3) 가열시킨 두유 100 중량부 대비 상기 두부용 응고제 0.1 내지 1 중량부를 첨가하여 두유 응고물을 얻는 단계; 및 (S4) 상기 두유 응고물을 압착성형하는 단계;를 포함하는 두부의 제조방법.
7. (S1) concentrating the underground brine until it has a concentration according to the above 1; (S2) mixing the black garlic extract with the concentrated underground brine to obtain a coagulant for tofu; (S3) adding 0.1 to 1 parts by weight of the coagulant for tofu relative to 100 parts by weight of the heated soy milk to obtain a soy milk coagulum; And (S4) compression molding the soy milk coagulum.
본 발명의 지하염수로부터 유래한 천연 응고제로 제조한 두부는 일체의 화학적 처리공정과 화학 첨가물이 들어가지 않은 방식을 사용함으로써, 기존의 화학 응고제가 가지고 있는 비안전성 및 거부감 등을 개선시키는 효과뿐만 아니라 완성된 두부의 맛과 부드러움이 뛰어나고, 건강기능성을 갖추고 있다. 또한 이에 흑마늘 추출액을 첨가함으로써 건강기능성과 기호성이 더욱 우수하다.
Tofu prepared with natural coagulants derived from the underground brine of the present invention by using a method that does not contain any chemical treatment process and chemical additives, as well as the effect of improving the safety and rejection of conventional chemical coagulants, etc. The taste and the softness of the finished tofu are excellent, and it has healthy functionality. In addition, the addition of black garlic extract is more excellent health functionality and palatability.
본 발명은, 30 brix 농축액 기준으로 칼슘 50,000 내지 70,000 mg/l, 마그네슘 500 내지 1,000 mg/l 및 나트륨 15,000 내지 40,000 mg/l를 함유하는 지하염수의 농축액; 및 흑마늘 추출액;을 포함함으로써, 기존의 화학 응고제가 가지고 있는 거부감 등을 개선시키는 효과뿐만 아니라 완성된 두부의 맛과 부드러움이 뛰어나며, 다양한 미네랄을 풍부하게 함유할 뿐만 아니라 흑마늘의 우수한 건강기능성을 갖는 두부 및 그 제조방법에 관한 것이다.
The present invention provides a concentrate of underground brine containing 50,000 to 70,000 mg / l of calcium, 500 to 1,000 mg / l of magnesium and 15,000 to 40,000 mg / l of sodium on a 30 brix concentrate; And black garlic extract; tofu not only improves the rejection of the existing chemical coagulant, but also has excellent taste and softness of the finished tofu, and contains abundant minerals as well as tofu having excellent health functionalities of black garlic. And to a method for producing the same.
이하 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명의 두부용 응고제는 지하염수의 농축액과 흑마늘 추출액을 포함하는 것을 특징으로 한다.The coagulant for tofu of the present invention is characterized in that it comprises a concentrated solution of underground brine and black garlic extract.
본 발명의 두부 응고제에 사용되는 지하염수는 염분을 가진 지하수로서, 삼투압이 높은 해수가 지층 구조에 따라 침투하여 지하수와 혼합되어 형성된 것으로 판단되는 수자원이다. 지하염수는 지하수의 생성 및 해수의 혼입 과정에서 지층 구조에 의한 여과 기능 및 지층에 포함된 미네랄의 용출 기능을 기대할 수 있으므로 인체에 무해할 뿐만 아니라 다양한 미네랄 성분을 포함함으로써 영양학적으로 우수한 수자원이다. 본 발명은 이러한 지하염수를 사용한 두부용 응고제를 제공하며, 이러한 본 발명의 두부용 응고제는 사용하여 인체에 무해하고 영양학적으로 우수하며 식감 및 기호성이 뛰어난 두부를 제조할 수 있다.Underground brine used in the coagulant of the present invention is a groundwater with salt, and is a water resource that is determined to be formed by mixing with the groundwater to penetrate the seawater with a high osmotic pressure according to the strata structure. Underground salt water is a nutritionally excellent water resource because it is not only harmless to the human body but also includes various mineral components because it can be expected to filter by the geological structure and the elution function of minerals contained in the strata during the groundwater generation and the mixing of seawater. The present invention provides a coagulant for tofu using such underground brine, and the coagulant for tofu of the present invention can be used to produce tofu that is harmless to the human body, nutritionally superior, and has excellent texture and palatability.
본 발명에 따른 지하염수는 농축액 형태로 두부 응고제에 함유된다. 지하염수를 두부용 응고제로 사용하기 위해서는 특정 성분이 특정한 함량 범위로 포함될 필요가 있다.Underground brine according to the invention is contained in tofu coagulant in the form of a concentrate. In order to use underground brine as a coagulant for tofu, certain ingredients need to be included in specific content ranges.
구체적으로, 본 발명에 따른 지하염수의 농축액은 30 brix 농축액 기준으로 칼슘 50,000 내지 70,000 mg/l, 마그네슘 500 내지 1,000 mg/l 및 나트륨 15,000 내지 40,000 mg/l를 함유한다.Specifically, the brine concentrate according to the present invention contains calcium 50,000 to 70,000 mg / l, magnesium 500 to 1,000 mg / l and sodium 15,000 to 40,000 mg / l based on 30 brix concentrate.
칼슘은 콩단백질의 응고에 관여할 뿐만 아니라, 제조된 두부에 부드러운 맛을 부여한다. 아울러, 칼슘은 인체의 뼈 생성에 기여한다. 본 발명에 따른 지하염수의 농축액은 칼슘을 상기 농축액 30 brix 기준으로 50,000 내지 70,000 mg/l 함량으로 포함하는 것을 특징으로 한다. 칼슘 함량이 50,000 mg/l 미만이면 두부의 응고량이 적어지고 제조되는 두부의 부드러운 식감 및 기호성이 저하되며, 70,000 mg/l 초과이면 제조되는 두부의 기호성이 저하되며, 상대적으로 다른 미네랄의 함량이 적어진다.Calcium not only participates in the coagulation of soy protein, but also gives a soft taste to the prepared tofu. In addition, calcium contributes to bone formation in the human body. Underground brine concentrate according to the present invention is characterized in that it contains calcium in the content of 50,000 to 70,000 mg / l based on the concentrate 30 brix. If the calcium content is less than 50,000 mg / l, the coagulation amount of the tofu is reduced, and the soft texture and palatability of the tofu is reduced. If the calcium content is more than 70,000 mg / l, the palatability of the tofu is produced, and the content of other minerals is relatively low Lose.
마그네슘은 콩단백질을 응고시키는 역할을 한다. 본 발명에 따른 지하염수의 농축액은 마그네슘을 상기 농축액 30 brix 기준으로 500 내지 1,000 mg/l 함량으로 포함하는 것을 특징으로 한다. 마그네슘 함량이 500 mg/l 미만이면 두부의 응고량이 적어지며, 1,000 mg/l 초과이면 제조되는 두부에 쓴맛이 강화되어 기호성이 저하된다.Magnesium coagulates soy protein. The concentrate of the underground brine according to the present invention is characterized in that it contains magnesium in an amount of 500 to 1,000 mg / l based on the concentrate 30 brix. If the magnesium content is less than 500 mg / l, the coagulation amount of the tofu is reduced. If the magnesium content is more than 1,000 mg / l, the bitterness of the prepared tofu is enhanced and the palatability is reduced.
나트륨은 콩단백질의 응고에 관여할 뿐만 아니라, 두부에 맛을 내는 성분이다. 본 발명에 따른 지하염수의 농축액은 나트륨을 상기 농축액 30 brix 기준으로 15,000 내지 40,000 mg/l 함량으로 포함하는 것을 특징으로 한다. 나트륨 함량이 15,000 mg/l 미만이면 두부의 기호성이 저하되고 두부 제조 수율이 저하될 수 있으며, 40,000 mg/l 초과이면 두부의 짠맛이 높아지고 기호성이 저하될 수 있다.Sodium is not only involved in the coagulation of soy protein, but is also an ingredient in tofu. The concentrate of the underground brine according to the present invention is characterized in that it comprises sodium in an amount of 15,000 to 40,000 mg / l based on the 30 brix of the concentrate. If the sodium content is less than 15,000 mg / l can be reduced the palatability of tofu and the yield of tofu production, and if more than 40,000 mg / l can increase the saltiness of the tofu and decrease the palatability.
선택적으로, 본 발명에 따른 지하염수의 농축액은 30 brix 농축액 기준으로 규소 5 내지 20 mg/l 및 아연 5 내지 20 mg/l를 더 함유할 수 있다. Optionally, the concentrate of the underground brine according to the invention may further contain 5 to 20 mg / l silicon and 5 to 20 mg / l zinc on a 30 brix concentrate basis.
아연은 세포를 구성하고 생리적인 기능을 다루는 대표적인 미네랄 중 하나로서, 본 발명의 지하염수 농축액은 다양한 미네랄을 포함하고 있으며, 특히 인체에 필수적인 미네랄로서 아연을 상기 범위의 함량으로 포함하여, 건강기능성을 더욱 강화할 수 있다.Zinc is one of the representative minerals constituting cells and dealing with physiological functions, and the underground saline concentrate of the present invention contains various minerals. You can strengthen it even more.
규소는 뼈의 형성에 있어 중요한 성분 중 하나로서, 본 발명에 따른 지하염수는 지층 사이에 존재하기 때문에, 지층으로부터 용출된 다양한 미네랄을 포함할 수 있으며, 그 중에서 규소 성분도 포함되는 것으로 판단된다. 본 발명의 지하염수 농축액은 규소를 상기 범위의 함량으로 포함하여, 건강기능성을 더욱 강화할 수 있다.Silicon is one of the important components in the formation of bone, and since the underground brine according to the present invention is present between the layers, it may include a variety of minerals eluted from the layers, including the silicon component. Underground brine concentrate of the present invention includes silicon in the content of the above range, it can further enhance the health functionality.
본 발명의 두부용 응고제에 있어서, 지하염수는 그 자체로는 미네랄의 농도가 낮아 콩단백질의 응고에 충분하지 않다. 그에 따라 본 발명에서는, 지하염수를 두부 제조에 용이하도록 농축하여 사용한다. 농축되는 농도는 두부의 용도 등 구체적인 필요에 따라 다양하게 조절이 가능하며, 예를 들면 20 내지 50 brix 일 수 있으나, 이에 한정되는 것은 아니다.In the coagulant for tofu of the present invention, underground brine is not sufficient for coagulation of soy protein due to its low concentration of minerals. Therefore, in the present invention, the underground brine is concentrated and used to facilitate the production of tofu. Concentration to be concentrated can be variously adjusted according to specific needs, such as the use of tofu, for example, may be 20 to 50 brix, but is not limited thereto.
농축방법은 당분야에서 사용되는 다양한 방법을 채택할 수 있으며, 예를 들면, 진공감압 농축법, 역삼투법, 이온교환 농축법, 직접가열 농축법, 태양광농축법(자연건조법) 중 적어도 하나를 사용할 수 있고, 두 방법 모두를 사용할 경우에는 각 방법을 순차적으로 사용할 수 있다. 바람직하게는 역삼투법 및 자연건조법 중 적어도 하나를 사용할 수 있다.The concentration method may adopt a variety of methods used in the art, for example, at least one of vacuum vacuum concentration method, reverse osmosis method, ion exchange concentration method, direct heating concentration method, solar concentration method (natural drying method) may be used. If both methods are used, each method can be used sequentially. Preferably, at least one of reverse osmosis and natural drying may be used.
농축공정을 거치기 전의 지하염수는 칼슘 4,000 내지 6,000 ppm, 마그네슘 20 내지 70 ppm 및 나트륨 1,500 내지 3,000 ppm 함량을 갖는 지하염수를 사용하는 것이 농축 후 전술한 농도의 미네랄 함량을 갖는 데에 바람직하다. 보다 바람직하게는 아연 및 규소의 함량도 각각 0.1 내지 1 ppm인 지하염수를 사용할 수 있다.Underground brine prior to the concentration process is preferably used to have a mineral content of the above-mentioned concentration after concentration using a base brine having a content of 4,000 to 6,000 ppm calcium, 20 to 70 ppm magnesium and 1,500 to 3,000 ppm sodium. More preferably, it is possible to use underground brine having a zinc and silicon content of 0.1 to 1 ppm, respectively.
본 발명에 따른 지하염수의 농축액에 있어서, 상기 성분들 외에 칼륨 등 지하염수에 포함되는 다양한 미네랄들이 본 발명의 두부 응고제에 포함될 수 있음은 당업자에게 자명하다.In the concentrate of the underground brine according to the present invention, it is apparent to those skilled in the art that various minerals included in the underground brine such as potassium may be included in the tofu coagulant of the present invention.
본 발명의 두부용 응고제는 흑마늘 추출액을 포함한다.The coagulant for tofu of the present invention includes black garlic extract.
흑마늘은 생마늘을 숙성 및/또는 발효시켜 제조된 가공 마늘로서 생마늘과는 다르게 그 색이 검정에 가까운 짙은 색을 갖는 가공 마늘이다.Black garlic is a processed garlic produced by ripening and / or fermenting fresh garlic, and is a processed garlic having a dark color close to black unlike raw garlic.
흑마늘은 일반마늘에 비해 활성산소를 제거하는 항산화 작용이 약 10배 이상 높은 것으로 알려져 있으며, 유해 산소를 제거하는 SOD(Super Oxide Dismutase) 함량이 높고, 폴리페놀 또한 10배 이상을 함유하고 있는 것이 알려져 있다. 또한, 항산화 물질인 S-아릴시스테인을 함유하고 있는 것으로 알려져 있다. 따라서 콜레스테롤 저하, 동맥경화 개선, 혈액의 정화 기능도 일반마늘에 비해 훨씬 높다. 흑마늘에는 일반 마늘에는 없는 안토시아닌 성분도 많아 인슐린 생성량을 50%까지 증가시켜 특히 심장병과 암 예방에 좋은 것으로 알려져 있다. 그 외에, 피로 회복, 소화촉진, 장운동 활성화, 간 기능 회복, 신경통 완화, 알레르기 억제, 해독작용, 살균, 항균작용, 면역력 강화, 순환기 질병 등에 효과가 있는 것으로 알려져 있다.It is known that black garlic has about 10 times higher antioxidant activity to remove free radicals than general garlic, has a high content of SOD (Super Oxide Dismutase) to remove harmful oxygen, and polyphenol also contains 10 times or more. have. It is also known to contain S-arylcysteine, which is an antioxidant. Therefore, cholesterol lowering, arteriosclerosis and blood purification are much higher than ordinary garlic. Black garlic has many anthocyanin compounds that are not found in garlic, which increases insulin production by up to 50%. In addition, it is known to be effective in fatigue recovery, digestion, intestinal motility, liver function recovery, neuralgia relief, allergy suppression, detoxification, sterilization, antibacterial action, strengthening immunity, circulatory disease.
본 발명에서는 흑마늘 추출액을 두부용 응고제에 포함하여 흑마늘의 건강기능성을 두부에 도입하는 것을 특징으로 한다.In the present invention, the black garlic extract is included in the coagulant for tofu, and the health function of black garlic is introduced into the tofu.
흑마늘은 당분야에 알려진 방법으로 제조된 것이라면 제한없이 사용될 수 있다. 예를 들면, 생마늘을 40 내지 90℃의 온도에서 10일 내지 30일간 숙성 및/또는 발효시켜 제조될 수 있다. 상기 숙성/발효 단계 전에 생마늘을 굽는 단계를 더 거칠 수도 있으며, 상기 숙성/발효 단계 후에 실온에서 숙성 및/또는 발효단계를 더 거칠 수도 있다. 다만, 상기 제조방법은 단순한 예시일 뿐 이에 한정되는 것은 아니다.Black garlic may be used without limitation as long as it is manufactured by a method known in the art. For example, raw garlic may be prepared by ripening and / or fermentation for 10 to 30 days at a temperature of 40 to 90 ℃. The raw garlic may be baked before the aging / fermentation step, and may be further subjected to the aging and / or fermentation step at room temperature after the aging / fermentation step. However, the manufacturing method is merely an example and is not limited thereto.
본 발명의 두부용 응고제에는 상기 흑마늘의 추출액을 사용한다. The extract of the black garlic is used as the coagulant for tofu of the present invention.
흑마늘의 추출은 당분야에 알려진 추출법을 제한없이 채택할 수 있다. 예를 들면 물(H2O)이나 에탄올 등의 알코올을 사용하여 통상적인 추출기로 추출할 수 있으며, 추출액은 필요에 따라 여과 단계를 거칠 수 있다. 또한, 필요에 따라 가열이나 역삼투 등을 통해 추출액을 농축하여 농축된 추출액을 사용할 수도 있다.Extraction of black garlic may employ any extraction method known in the art without limitation. For example, water (H 2 O) or alcohol such as ethanol may be used to extract with a conventional extractor, the extract may be subjected to a filtration step if necessary. In addition, the extract may be used by concentrating the extract through heating or reverse osmosis, if necessary.
본 발명의 두부용 응고제에 있어서, 지하염수의 농축액과 흑마늘 추출액의 혼합비는 당업자가 필요에 따라 적절하게 채택할 수 있다. 예를 들어, 지하염수 농축액:흑마늘 추출액= 90:10 내지 70:30의 혼합 중량비로 혼합될 수 있다. 지하염수 농축액의 혼합비가 7/10 미만이면 두유의 응고성능이 저하될 수 있으며, 9/10 초과이면 흑마늘 추출액의 첨가 효과가 미미할 수 있다.In the coagulant for tofu of the present invention, the mixing ratio of the concentrated solution of underground brine and the black garlic extract can be appropriately adopted by those skilled in the art as necessary. For example, the ground brine concentrate: black garlic extract may be mixed in a mixed weight ratio of 90:10 to 70:30. If the mixing ratio of the underground brine concentrate is less than 7/10, the coagulation performance of the soymilk may be lowered, and if more than 9/10, the addition effect of the black garlic extract may be insignificant.
본 발명의 두부용 응고제는 두부 제조에 사용되어 기호성이 및 건강 기능성이 우수한 두부를 제조할 수 있으며, 당분야에서 사용되는 두부의 제조에 특별한 제한없이 적용될 수 있다.The coagulant for tofu of the present invention may be used to prepare tofu to prepare tofu having excellent palatability and health functionality, and may be applied without particular limitation to the preparation of tofu used in the art.
이하에서는, 본 발명에 따른 두부의 제조방법의 일 구현예를 보다 상세하게 설명하도록 한다.Hereinafter, an embodiment of the manufacturing method of tofu according to the present invention will be described in more detail.
먼저, 지하염수를 전술한 농도를 가질 때까지 농축한다(S1).First, the underground brine is concentrated until it has the above concentration (S1).
취수된 지하염수는 농축공정을 거치기 전에 여과공정을 통해 이물질 및 불순물을 여과할 수 있다. 농축방법으로는 당분야에서 사용되는 다양한 방법이 제한없이 사용될 수 있으며, 예를 들면, 진공감압 농축법, 역삼투법, 이온교환 농축법, 직접가열 농축법, 태양광농축법(자연건조법) 중 적어도 하나를 사용할 수 있고, 두 방법 모두를 사용할 경우에는 각 방법을 순차적으로 사용할 수 있다. 바람직하게는 역삼투법 및 자연건조법 중 적어도 하나를 사용할 수 있다.Underground brine can be filtered through the filtration process to filter foreign substances and impurities. As the concentration method, various methods used in the art may be used without limitation, and for example, at least one of vacuum vacuum concentration method, reverse osmosis method, ion exchange concentration method, direct heating concentration method, and solar concentration method (natural drying method). If both methods are used, each method can be used sequentially. Preferably, at least one of reverse osmosis and natural drying may be used.
농축 후의 농도는 농도는 두부의 용도 등 구체적인 필요에 따라 다양하게 조절이 가능하며, 예를 들면 20 내지 50 brix 일 수 있으나, 이에 한정되는 것은 아니다.The concentration after concentration can be adjusted in various ways depending on the specific needs, such as the use of tofu, for example, may be 20 to 50 brix, but is not limited thereto.
다음으로, 상기 농축된 지하염수에 흑마늘 추출액을 혼합하여 두부용 응고제를 얻는다(S2).Next, black garlic extract is mixed with the concentrated underground brine to obtain a coagulant for tofu (S2).
흑마늘의 제조방법 및 흑마늘의 추출방법은 전술한 바와 같으며, 지하염수의 농축액과 흑마늘 추출액의 혼합비도 역시 전술한 바와 같이, 당업자가 필요에 따라 적절하게 채택할 수 있다. 예를 들어, 지하염수 농축액:흑마늘 추출액= 90:10 내지 70:30의 혼합 중량비로 혼합될 수 있다.The manufacturing method of black garlic and the extraction method of black garlic are as above-mentioned, The mixing ratio of the concentrate of underground brine and the black garlic extract can also be suitably employ | adopted by a person skilled in the art as needed above. For example, the ground brine concentrate: black garlic extract may be mixed in a mixed weight ratio of 90:10 to 70:30.
다음으로, 가열시킨 두유 100 중량부 대비 상기 두부용 응고제 0.1 내지 1 중량부를 첨가하여 두유 응고물을 얻는다(S3).Next, 0.1 to 1 parts by weight of the coagulant for tofu is added to 100 parts by weight of the heated soy milk to obtain a soy milk coagulum (S3).
두유는 당분야에서 통상적으로 사용되는 두유를 제한없이 사용할 수 있다. 두유의 제조방법을 개략적으로 설명하면 다음과 같다.Soy milk can be used without limitation soy milk commonly used in the art. The manufacturing method of soymilk is outlined as follows.
콩, 바람직하게는 대두를 깨끗한 물로 충분히 세척하고, 4 내지 25℃의 물에서 5 내지 48시간 동안 침지시켜 콩이 물을 충분히 흡수하도록 한다. 25℃를 초과하면 미생물의 증식이 활발하여 콩의 부패가 일어날 수 있고, 4℃ 미만에서는 콩에 물의 흡수가 충분히 되지 않을 수 있다. 또한, 48시간을 초과하여 침지시키면 미생물의 증식이 활발하여 콩의 부패가 일어날 수 있고, 5시간 미만으로 침지시키면 콩에 물의 흡수가 충분히 되지 않을 수 있다.The beans, preferably soybeans, are sufficiently washed with clean water and soaked in water at 4-25 ° C. for 5-48 hours to allow the beans to absorb enough water. If the temperature exceeds 25 ° C., the growth of microorganisms may be active, and soybean decay may occur. If the temperature is less than 4 ° C., water may not be sufficiently absorbed into the bean. In addition, if the immersion for more than 48 hours may be a proliferation of microorganisms active soybean decay, if less than 5 hours immersion may not be enough water absorption.
다음으로, 상기 물에 침지된 콩을 분쇄하여 콩즙을 얻고, 이를 여과하여 두유와 비지로 분리시켜 두유를 얻는다. 필요에 따라 콩즙의 여과 전에 가열단계를 더 거칠 수 있다.Next, the soybean immersed in water is pulverized to obtain a soy juice, which is filtered and separated into soy milk and sesame soybean milk. If necessary, the heating step may be further subjected to filtration of the soy juice.
제조된 두유에 본 발명의 두부용 응고제를 첨가하여 두유 응고물을 얻는다. 상기 제조된 두유가 가열단계를 거치지 않았다면 응고제 첨가 전에 두유를 가열한다. 그에 따라 두부용 응고제와 혼합 시에 두유의 온도는 70 내지 80℃가 바람직하다.Soymilk coagulum is obtained by adding the coagulant for tofu of the present invention to the prepared soymilk. If the prepared soy milk does not undergo a heating step, the soy milk is heated before the coagulant is added. Therefore, the temperature of the soymilk at the time of mixing with the tofu coagulant is preferably 70 to 80 ℃.
콩단백질의 응고작용에는 다양한 미네랄이 관여하는 것으로 알려져 있다. 본 발명의 두부용 응고제가 포함하는 지하염수의 농축액은 전술한 바와 같이 다량의 미네랄을 포함하고 있어 상기 응고의 속도가 빠르며, 높은 수율로 두유 응고물을 얻을 수 있다. 또한, 본 발명은 천연 응고제를 사용하기 때문에 인체에 무해하므로 응고제가 과량으로 투여된 경우에도 그 응고제를 제거하는 별도의 공정을 수행할 필요가 없으며, 이는 두부 제조에 필요한 시간을 단축하여 수율을 높일 수 있게 한다.Soy protein coagulation is known to be involved in a variety of minerals. The concentrated solution of underground brine contained in the coagulant for tofu of the present invention contains a large amount of minerals as described above, so that the coagulation rate is high and soymilk coagulum can be obtained in high yield. In addition, the present invention is harmless to the human body because it uses a natural coagulant, so even when the coagulant is administered in an excessive amount, there is no need to perform a separate process of removing the coagulant, which shortens the time required to prepare tofu and increases the yield. To be able.
두부용 응고제의 첨가량은 두유 100 중량부 대비 0.1 내지 1 중량부가 바람직하다. 두부용 응고제가 0.1 중량부 미만이면 얻어지는 두부의 양이 매우 적고 1 중량부 초과이면 제조되는 두부의 조직이 지나치게 치밀하여 식재료로 사용하기가 어려울 수 있다.The amount of the tofu coagulant added is preferably 0.1 to 1 parts by weight based on 100 parts by weight of soy milk. If the coagulant for tofu is less than 0.1 part by weight, the amount of tofu obtained may be very small, and if the amount of the tofu produced is too high, it may be difficult to use it as a food material because the tissue of the tofu produced is too dense.
다음으로, 상기 두유 응고물을 압착성형한다(S4).Next, the soymilk coagulum is press-molded (S4).
제조된 두유 응고물을 필요한 형태의 성형틀에 넣고 압착하여 순물(유청, whey)를 분리시키고 두부를 제조한다. The prepared soy milk coagulum is put into a mold of the required form and pressed to separate pure water (whey, whey) and tofu is prepared.
본 발명에 따라 제조되는 두부는 구체적인 용도에 따라 당분야에서 필요한 추가적인 공정을 거쳐 순두부, 연두부, 경두부, 유부 등으로 사용될 수 있다.The tofu prepared according to the present invention may be used as a soft tofu, soft tofu, cervical tofu, soybean paste, etc. through additional processes required in the art according to a specific use.
본 발명의 두부용 응고제로 제조된 두부는 지하염수에 포함된 미네랄 성분을 두부에 별도의 추가공정 없이 함유시킬 수 있으며, 특히 화학적으로 조성된 응고제가 아닌 천연 응고제를 사용하여 인체에 미네랄의 흡수도를 높일 수 있고, 흑마늘의 유효 성분을 함유하게 되어 흑마늘의 건강기능성도 갖게 된다.Tofu prepared by the coagulant for tofu of the present invention can contain the mineral component contained in the underground saline without any additional process, in particular, the absorption of minerals into the human body using a natural coagulant rather than chemically formed coagulant It can increase the, and contains the active ingredient of black garlic will also have the health function of black garlic.
특히, 본 발명의 두부는 높은 칼슘 함량을 갖는 것을 특징으로 한다. 예를 들면, 본 발명의 두부는 칼슘 400 내지 550 mg/kg, 바람직하게는 450 내지 550 mg/kg을 포함할 수 있다. 본 발명의 두부가 다량의 칼슘을 함유하는 이유로는 전술한 바와 같이 칼슘을 다량으로 함유하는 두부용 응고제를 사용했기 때문으로 판단된다. 따라서, 본 발명의 두부는 부드러운 맛이 더 우수할 뿐만 아니라 인체의 필수 미네랄인 칼슘의 섭취에 매우 유용한 것을 알 수 있다.In particular, the tofu of the present invention is characterized by having a high calcium content. For example, the tofu of the present invention may comprise 400 to 550 mg / kg of calcium, preferably 450 to 550 mg / kg of calcium. The reason why the tofu of the present invention contains a large amount of calcium is because the coagulant for tofu containing a large amount of calcium is used as described above. Therefore, the tofu of the present invention can be seen that not only the soft taste is better but also very useful for the intake of calcium, which is an essential mineral of the human body.
또한, 본 발명의 두부는 다른 미네랄도 높은 함량으로 포함한다. 예를 들어, 아연(Zn), 철(Fe) 등의 함량이 높다. 아연의 경우에는 30 내지 40 mg/kg, 철의 경우에는 30 내지 40 mg/kg로 포함되어 세포의 형성이나 혈액의 형성에 특히 효과적이므로, 본 발명의 두부는 건강기능성이 매우 높다.
In addition, the tofu of the present invention also contains a high content of other minerals. For example, the content of zinc (Zn), iron (Fe) is high. In the case of zinc 30 to 40 mg / kg, iron is included in the 30 to 40 mg / kg is particularly effective in the formation of cells or blood formation, the head of the present invention is very high health functional.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 이들 실시예는 본 발명을 예시하는 것일 뿐 첨부된 특허청구범위를 제한하는 것이 아니며, 본 발명의 범주 및 기술사상 범위 내에서 실시예에 대한 다양한 변경 및 수정이 가능함은 당업자에게 있어서 명백한 것이며, 이러한 변형 및 수정이 첨부된 특허청구범위에 속하는 것도 당연한 것이다. It is to be understood that both the foregoing general description and the following detailed description of the present invention are exemplary and explanatory and are intended to be illustrative of the invention and are not intended to limit the scope of the claims. It will be apparent to those skilled in the art that such variations and modifications are within the scope of the appended claims.
실시예Example
대한민국 경상남도 남해군 고현면 갈화리 지역의 지하 약 870m 부근에서 지하염수를 채취하였다. 채취된 지하염수를 역삼투 방식으로 24-26 Be°가 될 때까지 농축하여 1차 지하염수 농축액을 얻었다. 상기 1차 지하염수 농축액을 실온에서 자연건조 하여 30 brix가 될 때까지 농축하여 2차 농축액을 얻었다.Underground brine was collected about 870 meters underground in Galhwari, Gohyeon-myeon, Namhae-gun, Gyeongsangnam-do, Korea. The collected underground brine was concentrated by reverse osmosis until 24-26 Be ° to obtain a first underground brine concentrate. The primary underground brine concentrate was naturally dried at room temperature and concentrated to 30 brix to obtain a secondary concentrate.
다음으로, 상기 얻어진 지하염수의 농축액과 흑마늘 추출액(도울농산 제조)을 8:2의 중량비로 혼합하여 두부용 응고제를 제조하였다.Next, the concentrate of the underground brine and the black garlic extract (manufactured by Seoul Agricultural Co., Ltd.) were mixed at a weight ratio of 8: 2 to prepare a coagulant for tofu.
80℃로 가열시킨 두유 100 중량부에 상기 응고제 0.5 중량부를 혼합하여 두유 응고물을 얻은 후 상기 응고물을 성형틀에 넣고 압착하여 두부를 제조하였다.
0.5 parts by weight of the coagulant was mixed with 100 parts by weight of soymilk heated to 80 ° C. to obtain a soymilk coagulum.
비교예Comparative Example 1 및 2 1 and 2
시판되고 있는 두부들을 각각 비교예 1(부침두부, 풀무원 제조) 및 비교예 2(소가두부, 풀무원 제조)로 사용하였다.
Commercially available tofu was used in Comparative Example 1 (tofu tofu, Pulmuone) and Comparative Example 2 (small tofu, Pulmuone).
실험예Experimental Example
1. 농축 전 1. Before enrichment 지하염수의Underground saline 미네랄 성분 분석 Mineral component analysis
실시예에서 사용된 지하염수의 농축 전 미네랄 함량을 분석하였으며, 그 결과를 하기 표 1에 기재하였다(단위는 ppm).The mineral content before concentration of the underground brine used in the examples was analyzed, and the results are shown in Table 1 below (unit: ppm).
상기 표 1에 기재된 바와 같이, 본 발명에서 사용된 지하염수는 중금속이 포함되어 있지 않을 뿐만 아니라, 칼슘의 함량이 매우 높고, 상대적으로 마그네슘 함량이 작은 것을 알 수 있다.
As shown in Table 1, the underground brine used in the present invention not only does not contain heavy metals, it can be seen that the calcium content is very high, and the magnesium content is relatively small.
2. 2. 지하염수Underground brine 농축액의 미네랄 성분 분석 Analysis of mineral components in the concentrate
2차 농축단계를 거친 지하염수의 30 brix 농축액의 미네랄 함량을 분석하였으며, 그 결과를 하기 표 2에 기재하였다(단위는 mg/l).Mineral content of the 30 brix concentrate of the underground brine after the second concentration step was analyzed, the results are shown in Table 2 (unit: mg / l).
상기 표 2에 기재된 바와 같이, 본 발명의 지하염수 농축액은 칼슘 함량이 매우 높은 것을 알 수 있다. 다량의 칼슘으로 인해 콩단백질의 응고가 잘 이루어지며, 특히 두부의 부드러운 맛이 강화될 것임을 알 수 있다.As shown in Table 2, it can be seen that the underground brine concentrate of the present invention has a very high calcium content. Due to the large amount of calcium, soy protein coagulates well, especially the soft taste of tofu can be seen that.
또한, 상기 표 2에서 0.01 ppm 이하 또는 0.001 ppm 이하의 함량으로 기재한 것은 측정가능한 함량의 하한 미만인 것을 나타내는 것으로서, 이는 실질적으로 검출되지 않았음을 의미한다. 따라서 본 발명에 따른 지하염수의 농축액에는 인체에 유해한 중금속들이 실질적으로 포함되지 않았음을 확인하였다.
In addition, in Table 2, the content of 0.01 ppm or less or 0.001 ppm or less indicates that it is less than the lower limit of the measurable content, which means that it is not substantially detected. Therefore, it was confirmed that the concentration of underground brine according to the present invention was substantially free of heavy metals harmful to humans.
3. 두부의 미네랄 성분 평가3. Evaluation of Mineral Contents of Tofu
실시예 및 비교예 1-2의 두부들에 대해서, 주요 미네랄 성분을 측정하였으며, 그 결과를 하기 표 3에 기재하였다(단위는 mg/kg).For the tofu of Examples and Comparative Examples 1-2, the major mineral components were measured, and the results are shown in Table 3 below (unit: mg / kg).
상기 표 3에 기재된 바와 같이, 본 발명에 따른 실시예 두부의 경우에는 시판되는 비교예들의 두부에 비해 칼슘 함량이 현저하게 많은 것을 알 수 있다. 이로부터 본 발명의 두부는 비교예들의 두부보다 부드러운 맛이 더 우수할 뿐만 아니라 인체의 필수 미네랄인 칼슘의 섭취에 매우 유용한 것을 알 수 있다.As shown in Table 3, in the case of Example tofu according to the present invention, it can be seen that the calcium content is significantly higher than that of the tofu of commercial comparative examples. From this, the tofu of the present invention can be seen that not only has a softer taste than the tofu of the comparative examples, but also is very useful for the intake of calcium, which is an essential mineral of the human body.
또한, 본 발명에 따른 실시예의 두부는 아연 및 철 함량이 비교예들보다 높아 세포의 형성 및 혈액 형성 등에 특히 유리하다.In addition, the head of the embodiment according to the present invention has a higher zinc and iron content than the comparative examples, which is particularly advantageous for cell formation and blood formation.
Claims (7)
흑마늘 추출액;
을 포함하는 두부용 응고제.
A concentrate of underground brine containing 50,000 to 70,000 mg / l calcium, 500 to 1,000 mg / l magnesium and 15,000 to 40,000 mg / l sodium on a 30 brix concentrate basis; And
Black garlic extract;
Tofu coagulant comprising a.
The coagulant for tofu according to claim 1, wherein the underground brine before concentration contains 4,000 to 6,000 ppm calcium, 20 to 70 ppm magnesium and 1,500 to 3,000 ppm sodium.
The coagulant for tofu according to claim 1, wherein the brine concentrate further contains 5 to 20 mg / l silicon and 5 to 20 mg / l zinc on a 30 brix concentrate basis.
The coagulant for tofu according to claim 1, wherein the mixed weight ratio of the brine concentrate and the black garlic extract is 70:30 to 90:10.
Tofu made with the coagulant for tofu according to any one of claims 1 to 4.
The tofu of claim 5, comprising 400 to 550 mg / kg of calcium.
(S2) 상기 농축된 지하염수에 흑마늘 추출액을 혼합하여 두부용 응고제를 얻는 단계;
(S3) 가열시킨 두유 100 중량부 대비 상기 두부용 응고제 0.1 내지 1 중량부를 첨가하여 두유 응고물을 얻는 단계; 및
(S4) 상기 두유 응고물을 압착성형하는 단계
를 포함하는 두부의 제조방법.
(S1) concentrating the underground brine until it has a concentration according to claim 1;
(S2) mixing the black garlic extract with the concentrated underground brine to obtain a coagulant for tofu;
(S3) adding 0.1 to 1 parts by weight of the coagulant for tofu relative to 100 parts by weight of the heated soy milk to obtain a soy milk coagulum; And
(S4) compression molding the soy milk coagulum
Tofu manufacturing method comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120014223A KR101369252B1 (en) | 2012-02-13 | 2012-02-13 | Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120014223A KR101369252B1 (en) | 2012-02-13 | 2012-02-13 | Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130092748A KR20130092748A (en) | 2013-08-21 |
KR101369252B1 true KR101369252B1 (en) | 2014-03-04 |
Family
ID=49217352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120014223A KR101369252B1 (en) | 2012-02-13 | 2012-02-13 | Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101369252B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160088057A (en) | 2015-01-15 | 2016-07-25 | 김종학 | Arrowroot juice coagulant, Soybean Curd using the same and Manufacturing method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101943047B1 (en) * | 2016-12-26 | 2019-04-11 | 천년초선인장푸드창대 주식회사 | Coagulating agent for bean curd comprising opuntia humifusa extract |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070032749A (en) * | 2007-02-08 | 2007-03-22 | 조창근 | Method of manufacturing functional tofu |
KR100936441B1 (en) | 2007-11-05 | 2010-01-12 | 최용철 | Well taste of theready-to-eat bean curd and manufacturing method thereby |
KR20100009434A (en) * | 2008-07-18 | 2010-01-27 | 유영기 | Manufacturing technique of natural coagulant originated deep sea water |
KR20100126143A (en) * | 2009-05-22 | 2010-12-01 | 이정선 | Preparation method of bean-curd containing garlic |
-
2012
- 2012-02-13 KR KR1020120014223A patent/KR101369252B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070032749A (en) * | 2007-02-08 | 2007-03-22 | 조창근 | Method of manufacturing functional tofu |
KR100936441B1 (en) | 2007-11-05 | 2010-01-12 | 최용철 | Well taste of theready-to-eat bean curd and manufacturing method thereby |
KR20100009434A (en) * | 2008-07-18 | 2010-01-27 | 유영기 | Manufacturing technique of natural coagulant originated deep sea water |
KR20100126143A (en) * | 2009-05-22 | 2010-12-01 | 이정선 | Preparation method of bean-curd containing garlic |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160088057A (en) | 2015-01-15 | 2016-07-25 | 김종학 | Arrowroot juice coagulant, Soybean Curd using the same and Manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20130092748A (en) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103141898B (en) | Healthcare beverage compound with yam, black rice and peanut | |
KR101765764B1 (en) | Method of Manufacturing Soybean Curd Using Tropical Fruits | |
CN101990955B (en) | Sour milk bean curd and manufacturing method thereof | |
KR101898300B1 (en) | Manufacturing method of functional sun-dried salt | |
CN1262204C (en) | Natural lemon juice nutrient beacurd and its preparing method | |
JP2001292726A (en) | Liquid vegetable salt and method for producing the same | |
KR101128899B1 (en) | Manufacturing method of medicinal plant jangajji with function using enzyme | |
KR20110137698A (en) | Soybean paste sauce and method thereof | |
KR101128077B1 (en) | Manufacturing method of medicinal plant jangajji with low-salt using enzyme | |
KR101369252B1 (en) | Coagulating agent for bean curd comprising black garlic extract and underground salt water And Bean curd prepared by using the same | |
KR101417800B1 (en) | Using the method of Phellinus tofu | |
KR101478784B1 (en) | Manufacturing method of functional salt using chamaecyparis obtusa | |
KR20170001169A (en) | A method of preparing glasswort salt using solar salt and an glasswort | |
KR101249115B1 (en) | SOY SAUCE OR BEAN PASTE CONTAINING MELANIAN SNAILl AND MANUFACTURING THEREOF | |
KR100920675B1 (en) | A method of manufacture of soybean paste that use sea squirt and the soybean paste manufactured thereof | |
KR101046766B1 (en) | Manufacturing method of medicinal plant jangajji using enzyme | |
KR101805353B1 (en) | Manufacture method tea bean curd and bean burd thereof | |
KR101762674B1 (en) | The method of well-being soy sauce manufacture | |
KR100702813B1 (en) | Natural calcium manufacturing method using the salted anchovies residue | |
KR102266532B1 (en) | Low sodium alkaline soybean paste and manufacturing method thereof | |
KR102118252B1 (en) | Cheese milk bean curd and its manufacturing method | |
KR102013998B1 (en) | Sword Bean Milk Making Method and Sword Bean Milk made by the Making Method | |
KR101070821B1 (en) | Manufacturing Method of Salicomia Herbacea Tea | |
CN106721827A (en) | A kind of preparation method of red bean drink | |
CN107475055A (en) | A kind of Tea containing traditional Chinese medicine vinegar and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170118 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |